Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Patel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 51, iii13-iii21
© 2003 The British Society for Antimicrobial Chemotherapy


Supplement

Clinical impact of vancomycin-resistant enterococci

Robin Patel*

Division of Infectious Diseases, Department of Internal Medicine, Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Infectious Diseases Research Laboratory, Mayo Clinic and Foundation, 200 First St. S. W., Rochester, MN 55905, USA

Abstract

In humans, vancomycin-resistant enterococci (VRE) most commonly result in intestinal colonization, which does not result in symptoms, may persist for a long time and serves as a reservoir for transmission of VRE to other patients. Certain VRE-colonized patients are at risk of infection, including haematology and oncology patients, patients in intensive care units and recipients of solid (especially abdominal) organ transplants. Controlling the spread of VRE colonization and preventing colonized patients from becoming infected are important aims. Ramoplanin is a member of a new class of antimicrobial agents; it may have a role in preventing infection in patients colonized with VRE.

Keywords: enterococci, glycopeptide resistance, vancomycin

Footnotes

* Tel: +1-507-255-6482; Fax: +1-507-255-7767; E-mail: patel.robin{at}mayo.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
A. P. MacGowan and on behalf of the BSAC Working Parties on Resistanc
Clinical implications of antimicrobial resistance for therapy
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii105 - ii114.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
V. Vankerckhoven, G. Huys, M. Vancanneyt, C. Snauwaert, J. Swings, I. Klare, W. Witte, T. Van Autgaerden, S. Chapelle, C. Lammens, et al.
Genotypic Diversity, Antimicrobial Resistance, and Virulence Factors of Human Isolates and Probiotic Cultures Constituting Two Intraspecific Groups of Enterococcus faecium Isolates
Appl. Envir. Microbiol., July 15, 2008; 74(14): 4247 - 4255.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
S. S.Y. Wong, P.-L. Ho, and K.-Y. Yuen
EVOLUTION OF ANTIBIOTIC RESISTANCE MECHANISMS AND THEIR RELEVANCE TO DIALYSIS-RELATED INFECTIONS
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S272 - S280.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. S. Huang, R. Datta, and R. Platt
Risk of acquiring antibiotic-resistant bacteria from prior room occupants.
Arch Intern Med, October 9, 2006; 166(18): 1945 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
A. Zirakzadeh and R. Patel
Vancomycin-Resistant Enterococci: Colonization, Infection, Detection, and Treatment
Mayo Clin. Proc., April 1, 2006; 81(4): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
S. Kachroo, T. Dao, F. Zabaneh, M. Reiter, M. T LaRocco, L. O Gentry, and K. W Garey
Tolerance of Vancomycin for Surgical Prophylaxis in Patients Undergoing Cardiac Surgery and Incidence of Vancomycin-Resistant Enterococcus Colonization
Ann. Pharmacother., March 1, 2006; 40(3): 381 - 385.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.